|
21
|
Trapidil derivatives as potential antiatherosclerotic drugs.
Giessler C, Fahr A, Tertov VV, Kudryashov SA, Orekhov AN, Smirnov VN, Mest HJ
Arzneimittelforschung 1987 May 37:5 538-41
|
|
22
|
[Local prevention of thrombosis in the dog carotid artery using magnetically concentrated erythrocytes loaded with aspirin] [in Russian]
Orekhov AN, Beliaev AA, Orekhova NM, Samokhin GP, Ragimov SE
Biull Eksp Biol Med 1987 Aug 104:8 153-5
|
|
23
|
The gangliosides of adult human aorta: intima, media and plaque.
Prokazova NV, Orekhov AN, Mukhin DN, Mikhailenko IA, Kogtev LS, Sadovskaya VL, Golovanova NK, Bergelson LD
Eur J Biochem 1987 Sep 1 167:2 349-52
|
|
24
|
Diabetes mellitus and atherosclerosis [letter]
Slavina ES, Madanat AYa, Pankov YuA, Syrkin AL, Tertov VV, Orekhov AN
N Engl J Med 1987 Sep 24 317:13 836
|
|
25
|
Adult human aortic cells in primary culture: heterogeneity in shape.
Orekhov AN, Krushinsky AV, Andreeva ER, Repin VS, Smirnov VN
Heart Vessels 1986 2:4 193-201
|
|
26
|
Agents that increase cellular cyclic AMP inhibit proliferative activity and decrease lipid content in cells cultured from atherosclerotic human aorta.
Tertov VV, Orekhov AN, Smirnov VN
Artery 1986 13:6 365-72
|
|
27
|
Cyclic AMP and cyclic GMP content in a short-term organ culture of normal and atherosclerotic human aorta.
Tertov VV, Orekhov AN, Smirnov VN
Artery 1986 13:6 373-82
|
|
28
|
Monoclonal antibody reveals heterogeneity in human aortic intima: detection of a ganglioside antigen associated with a subpopulation of intimal cells [published erratum appears in Am J Pathol 1986 May;123(2):379]
Orekhov AN, Kalantarov GF, Andreeva ER, Prokazova NV, Trakht IN, Bergelson LD, Smirnov VN
Am J Pathol 1986 Mar 122:3 379-85
|
|
29
|
Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents.
Orekhov AN, Tertov VV, Kudryashov SA, Khashimov KhA, Smirnov VN
Atherosclerosis 1986 May 60:2 101-10
|
|
30
|
Atherogenicity of blood serum from patients with coronary heart disease.
Chazov EI, Tertov VV, Orekhov AN, Lyakishev AA, Perova NV, Kurdanov KA, Khashimov KA, Novikov ID, Smirnov VN
Lancet 1986 Sep 13 2:8507 595-8
|
